Nxera Pharma Co (TSE:4565) FFO


TSE:4565 Nxera Pharma Co Ltd TSE:4565
74 GF Score
Price 円954.00
GF Value 円1,308.23
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Nxera Pharma Co FFO?

FFO (Funds from operations) only applies to REITs.

TSE:4565
74GF Score
Nxera Pharma Co Ltd TSE:4565
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nxera Pharma Co (TSE:4565) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be undervalued. The current stock price of 円954.00 is trading 27.1% below its estimated GF Value™ of 円1,308.23. GuruFocus considers Nxera Pharma Co to be Modestly Undervalued.

Key valuation signals for TSE:4565:

  • FFO:
  • GF Value™: 円1,308.23 vs. price of 円954.00 (27.1% below fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the TSE:4565 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nxera Pharma Co Business Description

Other Exchanges SOLTF:USA
Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).
74GF Score

Get the complete analysis for TSE:4565

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円954.00
Price
円1,308.23
GF Value